Skip to main content

Find Clinical Trials

Home
Conditions
Skin Diseases, Vesiculobullous

Clinical trial condition

Skin Diseases, Vesiculobullous

Explore clinical trials studying Skin Diseases, Vesiculobullous. Study availability and eligibility vary by location and protocol.

235 public trials 35 recruiting studies

Refine in advanced search Browse all conditions

Skin Diseases, Vesiculobullous trial results

Completed

Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa

NCT03529877

Conditions: Collagen Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations: University of Minnesota, Masonic Cancer Center and Medical Center Minneapolis, Minnesota, United States

EB-Haus Austria; Salzburger Landeskliniken (SALK); Paracelsus Medizinische Privatuniversität Salzburg (PMU) Salzburg, Austria

Hôpital Saint-Louis; Département de dermatologie Paris, France

Department of Dermatology, Medical Center-University of Freiburg Freiburg im Breisgau, Germany

View Trial Details

Completed

National Registry for Ichthyosis and Related Disorders

NCT00074685

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Darier Disease, +28 more
Locations: University of Washington Seattle, Washington, United States

View Trial Details

Completed

Nutritional and Metabolic Management of Toxidermia Patients Requiring Intensive Care (TEN Metabolism)

NCT05320653

Conditions: Chemically-Induced Disorders, Dermatitis, Drug Eruptions, +15 more
Locations: Not specified

View Trial Details

Completed

Pro-Resolving Mediators in Acute Inflammation in Humans

NCT04308889

Conditions: Blister, Dermatitis, Inflammation; Skin, +6 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Topical Gentamicin Nonsense Suppression Therapy of EB

NCT04644627

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Epidermolysis Bullosa, +6 more
Locations: Oslo University Hospital Oslo, Norway

View Trial Details

Completed

Safety, Tolerability and Activity of BIVV009 in Healthy Volunteers and Patients With Complement Mediated Disorders

NCT02502903

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +25 more
Locations: Medical University of Vienna Vienna, Austria

View Trial Details

Completed

Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study

NCT02960997

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Epidermolysis Bullosa, +9 more
Locations: Stanford University Palo Alto, California, United States

View Trial Details

Completed

Index Individuals in SARS-CoV-2 Prevention Research Studies (COVID-19 Index Individuals Companion Study)

NCT05074719

Conditions: COVID-19, Chronic Disease, Coronaviridae Infections, +24 more
Locations: University of Washington International Clinical Research Center Seattle, Washington, United States

View Trial Details

Completed

Evaluation of the Improvement of Quality of Life of Patients Suffering From Hailey Hailey or Darier Disease After Injections of Botulism Toxin Into Large Folds.

NCT02782702

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Darier Disease, Genetic Diseases, Inborn, +7 more
Locations: Not specified

View Trial Details

Completed

Cutaneous Manifestations of Coronavirus Disease 2019(COVID-19).

NCT05094687

Conditions: Bacterial Infections and Mycoses, Blood Coagulation Disorders, COVID-19, +72 more
Locations: Jinnah Postgraduate Medical Centre Karachi, Sindh, Pakistan

View Trial Details